Medication-Based Treatment to Address Opioid Use Disorder.

In this Viewpoint the president of NAM and the former CEO of AAAS emphasize the importance of approaching opioid use disorder (OUD) as a chronic brain disease and of using evidence-based FDA-approved interventions to manage it, urging clinicians to overcome any personal biases that might interfere with provision of evidence-based care to help patients with OUD recover from their addiction. [ABSTRACT FROM AUTHOR]